In more than half of MM patients, CXCL8 is produced by MSCs in the bone marrow microenvironment [64,73], whereas in MGUS patients and healthy individuals, MSCs in the bone marrow produce low levels of CXCL8. Here, CXCL8 is linked to Miyoshi myopathy.